Research and analysis

Mpox: transmission, infectious and incubation periods

This rapid review identified and summarised evidence published before 15 August 2022 relating to mpox (monkeypox) (clade II) transmission, and mpox infectious and incubation periods.

From:
UK Health Security Agency
Published
2 March 2023
Last updated
23 January 2025 — See all updates

This publication was withdrawn on

This rapid review has been withdrawn and superceded by:

The rapid review ‘Mpox: adherence and barriers to isolation’ is still available and has been published in a separate location.

Documents

[Withdrawn] Mpox: transmission, and infectious and incubation periods: a rapid review

Ref: GOV-14169

PDF, 1.47 MB, 31 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This rapid review identified and summarised the evidence relating to:

  • mpox (clade II) transmission
  • mpox infectious and incubation periods

The rapid review searched for research published up to 15 August 2022 and includes:

  • one review for pre-2022 outbreaks
  • 30 studies from 2022 on the transmission of mpox
  • no studies on mpox infectious periods
  • 8 studies on mpox incubation periods
  • 21 studies from 2022 for whether environmental or individual samples contained mpox DNA or live mpox virus

Updates to this page

Published 2 March 2023
Last updated 23 January 2025 + show all updates

  1. This review has been withdrawn.

  2. Moved 'Mpox: adherence and barriers to following isolation guidance: a rapid review' to separate page.

  3. First published.

Sign up for emails or print this page

Related content